Just read the following on yahoo finance.
Dendreon Corp. (DNDN) : The drugmaker withdrew its sales estimates for 2011 and announced job cuts because of lower-than- expected growth in the use of prostate-cancer treatment Provenge.
Now what does this have to do with PRR. the issue with DNDN is a failure in the companies ability to forecast correctly.
If PRR investors sold due to DNDN they have no idea at all. I think it's a good thing for remaining holders as we rid ourselves of these fear driven traders.
why would dndn impact prr
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.5¢ | 32.0¢ | $1.303M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29843 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 105523 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |